Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug
United States Antimony (NYSE:UAMY) said on Sunday (October 19) that it is proposing to acquire Australian company Larvotto Resources (ASX:LRV). In a takeover
Gold Fields (NYSE:GFI) has completed its AU$3.7 billion purchase of Gold Road Resources. Gold Road rejected Gold Fields’ first acquisition proposal in March,
China has accused the US of “seriously distorting and exaggerating” Beijing’s newly expanded rare earths export controls, but signaled a willingness to
Jindalee Lithium (JLL:AU) has announced Proposed issue of securities – JLL Download the PDF here. This post appeared first on investingnews.com
Here’s a quick recap of the crypto landscape for Friday (October 17) as of 9:00 p.m. UTC. Get the latest insights on
Atlantic Lithium (A11:AU) has announced Pronounced Lithium-in-soil Anomalies Download the PDF here. This post appeared first on investingnews.com
Trading resumes in: Company: Cardiol Therapeutics Inc. TSX Symbol: CRDL All Issues: Yes Resumption (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension
(TheNewswire)
Manhattan Showing with assay results returning uranium grades ranging from 0.72% to 8.10% U3O8 in outcrop grab samples. Standard Uranium Ltd. (TSXV: STND,OTC:STTDF) (OTCQB: